Kolexia
Lesoin Anne-Flore Gynécologie
Lesoin Anne-Flore
Gynécologie
Cabinet libéral
Mérignies, France
50 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs de l'ovaire Carcinome épithélial de l'ovaire Récidive tumorale locale Tumeurs du péritoine Carcinomes Tumeurs de la trompe de Fallope Adénocarcinome Tumeurs épithéliales épidermoïdes et glandulaires Hypersensibilité

Collaborateurs

Voir plus
Floquet Anne
Floquet Anne
Institut Bergonié, Bordeaux, France
Joly Florence
Joly Florence
Hôpital Côte de Nacre, Caen, France
Pujade-Lauraine Eric
Pujade-Lauraine Eric
Hôpital Hôtel-Dieu Paris, Paris, France
Follana Philippe
Follana Philippe
Centre Antoine Lacassagne, Nice, France

Industries

Voir plus
B3TSI
34 collaboration(s)
Dernière en 2023
BVA (2)
1 collaboration(s)
Dernière en 2022
Bayer
1 collaboration(s)
Dernière en 2022
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
MYCA: Phase Ib / II Trial Evaluating the Association Myocet ® - Carboplatine in Patients Having a Cancer of the Ovary in Relapse, Sensitive to the Platinum
Essai Clinique (ARCAGY/ GINECO GROUP)   05 septembre 2023
A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer: A Phase 3 Randomized Double-blind Trial of Maintenance With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer.
Essai Clinique (Tesaro)   31 mai 2023
A phase II study of Navitoclax (ABT-263) as single agent in women heavily pretreated for recurrent epithelial ovarian cancer: The MONAVI - GINECO study.
Gynecologic oncology   02 février 2022
Efficacy and Safety of Pazopanib Monotherapy After First Line Chemotherapy in Ovarian, Fallopian Tube, or Primary Peritoneal Cancer: A Phase III Study to Evaluate the Efficacy and Safety of Pazopanib Monotherapy Versus Placebo in Women Who Have Not Progressed After First Line Chemotherapy for Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Essai Clinique (Novartis)   27 janvier 2021
Prospective study of serum and aqueous humour anti-Hsp70.1 IgG antibody levels in ocular toxoplasmosis.
Parasite immunology   07 août 2020
Final results from GCIG/ENGOT/AGO-OVAR 12, a randomised placebo-controlled phase III trial of nintedanib combined with chemotherapy for newly diagnosed advanced ovarian cancer.
International journal of cancer   06 septembre 2019
Development and validation of a prognostic nomogram for overall survival in patients with platinum-resistant ovarian cancer treated with chemotherapy.
European journal of cancer (Oxford, England : 1990)   03 juillet 2019
Niraparib Maintenance Therapy in Patients With Recurrent Ovarian Cancer After a Partial Response to the Last Platinum-Based Chemotherapy in the ENGOT-OV16/NOVA Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology   07 juin 2019
MONAVI-1: A Study of ABT-263 as Single Agent in Women With Platinum Resistant/Refractory Recurrent Ovarian Cancer
Essai Clinique (Centre François-Baclesse)   15 mars 2019
Alisertib in Combination With Weekly Paclitaxel in Patients With Advanced Breast Cancer or Recurrent Ovarian Cancer: A Randomized Clinical Trial.
JAMA oncology   10 janvier 2019